Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Researchers Identify Genes Linked to the Development of Monogenic Diabetes

By LabMedica International staff writers
Posted on 02 Mar 2020
By studying a well controlled group of young Lithuanian diabetes patients, researchers were able to identify genes linked to the development of the rare monogenic form of diabetes.

Monogenic diabetes, which results from a mutation in one of the genes involved in the regulation of blood sugar levels, represents approximately one to 4% of all cases of the disease. More...
Monogenic diabetes is frequently confused with type I or type II diabetes, and more than 90% of monogenic cases are misdiagnosed.

To correct this situation, investigators at the Université de Genève (Switzerland) and the Lithuanian University of Health Sciences (Vilnius) took advantage of the fact that Lithuania has a register of all diabetic children, which also includes most of the young adults. For the current study, the investigators assessed 1209 pediatric and young adult diabetic patients for diabetes-related autoimmune antibodies. They then screened all antibody-negative patients using targeted high-throughput sequencing of more than 300 potential candidate genes.

Results revealed that in the group of 153 patients lacking autoimmune antibodies, 40.7% had monogenic diabetes, with the highest percentage (100%) in infants (diagnosis at ages 0–12 months), followed by those diagnosed at ages from one to 18 years (40.3%) and at 18 to 25 years (22.2%).

The overall prevalence of monogenic diabetes in diabetic youth in Lithuania was 3.5% (1.9% for glucokinase diabetes, 0.7% for hepatocyte nuclear factor 1 homeobox A, 0.2% for hepatocyte nuclear factor 4 alpha and ATP binding cassette subfamily C member 8, 0.3% for potassium inwardly rectifying channel subfamily J member 11, and 0.1% for insulin). Likely pathogenic variants were also detected in 11 additional genes.

"Hyperglycemia should therefore be considered as a symptom of various diseases, rather than a disease in itself, and different forms of diabetes should be better screened," said senior author Dr. Valérie Schwitzgebel, professor of pediatrics, gynaecology, and obstetrics at Université de Genève. "The earlier the actual cause is identified, the sooner appropriate treatments can be initiated, minimizing the risk for long term complications."

The monogenic diabetes paper was published in the February 21, 2020, online edition of the journal Diabetes.

Related Links:
Université de Genève
Lithuanian University of Health Sciences



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.